Indus Pharma Profile
Key Indicators
- Authorised Capital ₹ 7.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 38 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.00 Cr
- Satisfied Charges ₹ 20.57 Cr
- Revenue Growth -58.06%
- Profit Growth -81.69%
- Ebitda -75.54%
- Net Worth 6.77%
- Total Assets -7.53%
About Indus Pharma
Indus Pharma Private Limited (IPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 12 January 1987 and has a history of 38 years and one month. Its registered office is in New Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹12.00 Cr. The company has closed loans amounting to ₹20.57 Cr, as per Ministry of Corporate Affairs (MCA) records.
Surinder Arora, Mukta Arora, and Radhey Arora serve as directors at the Company.
Company Details
- Location
New Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74899DL1987PTC026657
- Company No.
026657
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jan 1987
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Indus Pharma Private Limited offer?
Indus Pharma Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Anti Smoking Drugs, Anti Infective Drugs & Medicines, HIV Drugs, Anti Infective Agent, TB, Tumor & Cancer Drugs, Anti Cancer Medicines.
Who are the key members and board of directors at Indus Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Radhey Arora  | Managing Director | 12-Jan-1987 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Surinder Arora | Director | 15-Jun-2016 | Current |
| Mukta Arora | Director | 15-Jun-2016 | Current |
Financial Performance of Indus Pharma.
Indus Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 58.06% decrease. The company also saw a substantial fall in profitability, with a 81.69% decrease in profit. The company's net worth moved up by a moderate rise of 6.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indus Pharma?
In 2023, Indus Pharma had a promoter holding of 99.82% and a public holding of 0.18%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹120.00 M
₹205.67 M
Charges Breakdown by Lending Institutions
- Others : 12.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Sep 2020 | Others | ₹6.00 Cr | Open |
| 21 Sep 2020 | Others | ₹6.00 Cr | Open |
| 26 Sep 2018 | Others | ₹4.25 Cr | Satisfied |
| 12 Jan 2017 | Sidbi | ₹3.25 Cr | Satisfied |
| 12 Jan 2017 | Sidbi | ₹7.70 Cr | Satisfied |
How Many Employees Work at Indus Pharma?
Indus Pharma has a workforce of 46 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indus Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indus Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
